IL117591A0 - Synthetic DNA encoding human papillomavirus type 11 L1 protein - Google Patents

Synthetic DNA encoding human papillomavirus type 11 L1 protein

Info

Publication number
IL117591A0
IL117591A0 IL11759196A IL11759196A IL117591A0 IL 117591 A0 IL117591 A0 IL 117591A0 IL 11759196 A IL11759196 A IL 11759196A IL 11759196 A IL11759196 A IL 11759196A IL 117591 A0 IL117591 A0 IL 117591A0
Authority
IL
Israel
Prior art keywords
protein
synthetic dna
human papillomavirus
pct
papillomavirus type
Prior art date
Application number
IL11759196A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27022236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL117591(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL117591A0 publication Critical patent/IL117591A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL11759196A 1995-03-30 1996-03-21 Synthetic DNA encoding human papillomavirus type 11 L1 protein IL117591A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41357295A 1995-03-30 1995-03-30
US41357195A 1995-03-30 1995-03-30

Publications (1)

Publication Number Publication Date
IL117591A0 true IL117591A0 (en) 1996-07-23

Family

ID=27022236

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11759196A IL117591A0 (en) 1995-03-30 1996-03-21 Synthetic DNA encoding human papillomavirus type 11 L1 protein

Country Status (21)

Country Link
US (1) US6159729A (pl)
EP (1) EP0817852B1 (pl)
JP (1) JP3918877B2 (pl)
KR (1) KR100441477B1 (pl)
CN (1) CN1154732C (pl)
AT (1) ATE247712T1 (pl)
AU (1) AU708111B2 (pl)
CZ (1) CZ291375B6 (pl)
DE (1) DE69629556T2 (pl)
DK (1) DK0817852T3 (pl)
EA (1) EA000969B1 (pl)
ES (1) ES2203691T3 (pl)
HU (1) HU228490B1 (pl)
IL (1) IL117591A0 (pl)
NO (1) NO320086B1 (pl)
NZ (1) NZ306663A (pl)
PL (1) PL183299B1 (pl)
PT (1) PT817852E (pl)
SK (1) SK283998B6 (pl)
WO (1) WO1996030520A2 (pl)
ZA (1) ZA962526B (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2200582C (en) * 1994-09-22 2007-03-27 Merck & Co., Inc. Dna encoding human papillomavirus type 6a
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
PL336715A1 (en) * 1997-04-08 2000-07-03 Merck & Co Inc Stabilised formulation of human papilloma virus
SK2232001A3 (en) * 1998-08-14 2001-08-06 Merck & Co Inc Process for purifying human papillomavirus virus-like particles
DE19840263C1 (de) 1998-09-03 2000-05-25 Deutsches Krebsforsch Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen
US6380364B1 (en) 1998-11-23 2002-04-30 Loyola University Of Chicago Chimeric biotin-binding papillomavirus protein
AUPP765398A0 (en) 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
EP1150712B1 (en) 1999-02-05 2008-11-05 Merck & Co., Inc. Human papilloma virus vaccine formulations
US7001995B1 (en) * 1999-08-25 2006-02-21 Merck & Co., Inc. Synthetic human papillomavirus genes
SI1421200T1 (sl) * 2001-08-23 2007-04-30 Merck & Co Inc Poskusi PCR fluorescentnih multipleks HPV-jev z uporabo vec fluoroforov
EP1302550A1 (en) * 2001-10-10 2003-04-16 King Car Food Industrial Co., Ltd. Method and detector for identifying subtypes of human papilloma viruses
AU2004220549B2 (en) * 2003-03-07 2007-07-05 Instituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Influenza virus vaccine
CN100506999C (zh) 2003-03-24 2009-07-01 麦克公司 Hpv31l1在酵母中的优化表达
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
US7527948B2 (en) * 2003-09-25 2009-05-05 Third Wave Technologies, Inc. Detection of HPV
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast
MY139500A (en) * 2003-11-12 2009-10-30 Merck Sharp & Dohme Optimized expression of hpv 58 l1 in yeast
CA2560487C (en) * 2004-03-24 2013-01-29 Merck & Co., Inc. Optimized expression of hpv 52 l1 in yeast
US7354719B2 (en) 2004-12-08 2008-04-08 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
CN101341257B (zh) * 2004-12-10 2012-10-10 杰纳罗生物系统有限责任公司 使用核酸探针、微珠和荧光激活的细胞分选器(facs)检测人乳头状瘤病毒(hpv)
KR20080084809A (ko) * 2005-11-15 2008-09-19 게노이드 케이에프티. 병원체를 검출하는 방법
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
CN101200696B (zh) * 2007-11-14 2011-07-20 山东大学 人乳头瘤病毒的酵母增殖模型及建立方法与应用
KR20090073987A (ko) * 2007-12-31 2009-07-03 정운원 인간유두종바이러스 유전자형 검사를 위한 프라이머, 프로브 및 이를 포함하는 ｄｎａ칩, 이의 검사 방법 및 검사 키트
JP6153866B2 (ja) 2010-05-25 2017-06-28 キアゲン ガイサーズバーグ アイエヌシー． 迅速なハイブリッド捕捉アッセイ、及び関連する戦略的に切断されたプローブ
WO2012065034A1 (en) 2010-11-12 2012-05-18 Merck Sharp & Dohme Corp. Enolase peptide conjugate vaccines against staphylococcus aureus
BR112013032338B1 (pt) * 2011-06-15 2021-04-20 Posvax Co., Ltd método para melhorar o rendimento de produção para proteína l1 do papilomavírus humano
JP6920694B2 (ja) * 2015-12-04 2021-08-18 シアメン ユニバーシティＸｉａｍｅｎ Ｕｎｉｖｅｒｓｉｔｙ ヒトパピローマウイルスタイプ１１のｌ１タンパク質の突然変異
BR112021005626A2 (pt) * 2018-09-26 2021-06-29 Xiamen University mutante de proteína l1 de papilomavírus humano de tipo 51

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651727B2 (en) * 1991-07-19 1994-07-28 Csl Limited Papilloma virus vaccine
PT1618888E (pt) * 1993-03-09 2011-04-08 Univ Rochester Produção de proteína da cápside de vírus de papiloma humano e partículas semelhantes a vírus

Also Published As

Publication number Publication date
US6159729A (en) 2000-12-12
DE69629556D1 (de) 2003-09-25
AU708111B2 (en) 1999-07-29
KR100441477B1 (ko) 2004-10-06
WO1996030520A2 (en) 1996-10-03
PT817852E (pt) 2003-12-31
NZ306663A (en) 1999-10-28
DE69629556T2 (de) 2004-06-17
NO320086B1 (no) 2005-10-24
HU228490B1 (en) 2013-03-28
SK283998B6 (sk) 2004-07-07
EP0817852B1 (en) 2003-08-20
CN1185810A (zh) 1998-06-24
EA000969B1 (ru) 2000-08-28
SK129397A3 (en) 1998-05-06
HUP9801608A3 (en) 1999-04-28
DK0817852T3 (da) 2003-11-24
CZ309197A3 (cs) 1998-02-18
KR19980703391A (ko) 1998-10-15
PL183299B1 (pl) 2002-06-28
JPH11503313A (ja) 1999-03-26
EA199700281A1 (ru) 1998-04-30
ZA962526B (en) 1996-09-04
ATE247712T1 (de) 2003-09-15
WO1996030520A3 (en) 1996-11-07
NO974514L (no) 1997-11-27
JP3918877B2 (ja) 2007-05-23
HUP9801608A2 (hu) 1998-10-28
CN1154732C (zh) 2004-06-23
PL322588A1 (en) 1998-02-02
EP0817852A2 (en) 1998-01-14
NO974514D0 (no) 1997-09-29
CZ291375B6 (cs) 2003-02-12
ES2203691T3 (es) 2004-04-16
AU5527796A (en) 1996-10-16

Similar Documents

Publication Publication Date Title
IL117591A0 (en) Synthetic DNA encoding human papillomavirus type 11 L1 protein
HUP9801639A3 (en) Genetic sequences and proteins related to alzheimer's disease, and uses therefor
MY132529A (en) Paroxetine hydrochloride anhydrate
NZ306009A (en) Medical database system, unique identifier assigned to files, machine readable version of identifier included in hard copies
IL117848A0 (en) Novel compounds a process for their production and pharmacetical compositions containing same
HUP9801116A3 (en) Item of clothing, especially disposable clothing for use once only
NL300273I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
ATE198624T1 (de) Expression von albumin in hefe
BG102362A (en) New derivatives of amino acids, their preparation and application
BG101338A (en) Dna encoding human papillomavirus type 6a
MX9709398A (es) N-aril-1,2,4-triazolin-5-onas.
IL122606A (en) (S)-hydroxa-nitrile-lyase
GB9515411D0 (en) N-(4-substituted-benzyl)-2-aminolactam derivatives
PL288833A1 (en) Method of purifying 1,1,1-tris/4'-hydroxyphenyl/ethane
BG102707A (en) New triazolopurinpurines, method for their preparation and appplication as medicamentous forms
MX9707457A (es) Acido desoxirribonucleico sintetico hibrido l1 de hpv6/11 que codifica proteina l1 de virus de papiloma humano tipo 11.
HK1005651A1 (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
DE59611353D1 (de) Transketolase-verwandtes protein
DE59702821D1 (en) Dimethyl-substituierte cyclohexandienderivate
ES2191785T3 (es) Proteina de accion antitumoral.
CA2216827A1 (en) Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
IL98850A0 (en) Pristinamycin derivative and its preparation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired